Weiner presented results from a small trial testing a different way to bolster T-regs and quash cytotoxic T cells. Foralumab binds the TCR co-receptor, CD3. Weiner told Alzforum that how this antibody ...

Newly discovered oncology drugs called “DNA-encoded tri-specific T-cell engagers,” or “DTriTEs,” engage the immune system ...

The DeGregorio Family Foundation with support from the Torrey Coast Foundation has awarded $450,000 to Eric Smith, MD, PhD, ...

Autoimmune thyroid disease (AITD) causes cellular damage and alters thyroid gland function by humoral and cell-mediated mechanisms. Cellular damage occurs when sensitized T-lymphocytes and/or ...

Donald Trump and RFK have caused mayhem in the US medical research market. It's clearing a path for Aussie drug trial contractor IDT.

We are investigating the mechanisms by which cancer mutations deregulate the normal processes of cellular function and growth ...

Scientists from the Keck School of Medicine at University of Southern California have developed a spectral flow ...

This report describes a usually mild syndrome, dubbed LICATS, affecting about three-quarters of CAR T-cell recipients.

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...